SD

Shankarlal Devendra

Director Partner DIN 00050440
DIN 00050440 First appointment May 1973 Primary industry Business Outsourcing
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 15 historical roles
Total affiliations 15 Since May 1973
Shareholding value β€’β€’β€’β€’ Premium profile
Directorship timeline
First appointment 13 May 1973
Active appointments 6
Total timeline records 15

Shankarlal Devendra (DIN 00050440) has 15 recorded board appointments in Indian companies, the first from May 1973, of which 6 are current. The chart and the list below show each company, the role held and the years of the appointment, as filed with the Ministry of Corporate Affairs.

Appointment history

Since 1973
Axxelent Pharmaceuticals Private Limited Director · 2019 – present
Current
Dr.S.Devendra Trading Llp Designated Partner · 2014 – present
Current
Shasun Pharmaceuticals Limited Whole-Time Director · 2006 – present
Current
Shasun Life Sciences Private Limited Director · 2005 – present
Current
Shasun Biotech Limited Director · 1992 – present
Current
Devendra Estates Private Limited Director · 1973 – present
Current
Axxelent Pharma Science Private Limited Director · 2019 – 2021
Previous
Viyash Scientific Limited Additional Director · 2015 – 2016
Previous
Shasun Enterprises Llp Designated Partner · 2015 – 2020
Previous
Alivira Animal Health Limited Additional Director · 2014 – 2014
Previous
Devicam Capital Llp Partner · 2014 – 2014
Previous
Madras Boat Club Director · 2009 – 2010
Previous
Dharshini Industries Private Limited Director · 1994 – 2008
Previous
Dolariel Financial Services Limited Director · 1993 – 2011
Previous
Shasun Leasing And Finance Pvt Ltd Director · 1988 – 2023
Previous

Interactive timeline

Hover bars for tenure details
Loading chart...
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available